GP Pharm is a privately owned company that belongs to the Lipotec SA Group and to financial/industrial investors. GP Pharm began operations in 2002 acquiring the R&D pipeline and patent rights of the drug delivery division of Lipotec SA. The company is focused in the development of new delivery systems applied to drug products for the fields of Urology and Oncology.